Fingerprint
Dive into the research topics of 'Efficacy and safety of rovalpituzumab tesirine in third-line and beyond patients with DLL3-expressing, relapsed/refractory small-cell lung cancer: Results from the phase II TrINITY study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically